Articles by Stephanie Sutton - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Stephanie Sutton

EFPIA Calls for Urgent Action on German Pricing

Jun 14, 2012

The European Federation of Pharmaceutical Industries and Associations has called for the German government to take "urgent action" regarding its pricing system, which is perceived as hindering the market entry of new, innovative medicines in the country.

Dr. Reddy's and Merck Serono Team Up on Biosimilars

Jun 7, 2012

Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.

Antibiotic Resistance Program Launched in Europe

May 31, 2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the launch of a EUR 223.7-million ($276.5 million) program to tackle antimicrobial resistance and speed up the development of new antibiotics.

UK Condemns Parallel Trade

May 24, 2012

A recent report from the UK?s All Party Pharmacy Group (APPG) has attributed shortages of prescription medicines in the country to parallel trade and is calling for urgent action.

Big Pharma Bands with Academia in $23-Million Deal

May 17, 2012

AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceutica NV, Merck Serono, and Pfizer have pledged support of more than £14 million ($23 million) to a translational drug development project being run by the UK's Medical Research Council and the University of Dundee.

EFPIA Advances Medicines Verification Project

May 10, 2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has formally adopted a memorandum of understanding (MoU) with key partners for a harmonised, European system for medicines verification.

Anticounterfeiting Strategy Launched in UK

May 3, 2012

The UK's Medicines and Healthcare products Regulatory Agency has launched a new anticounterfeiting strategy with the aim of curbing the occurrence of falsified medicines in the county's supply chain.

GSK Collaborates on New Class of Medicines

May 2, 2012

GlaxoSmithKline has partnered with Yale University to design a potential new class of medicines that could be beneficial in areas such as oncology, inflammation, and infection.

Applying Quality by Design to Lyophilization

Featuring expert insights from GSK Biologicals, Baxter Pharmaceutical Solutions, GEA Pharma Systems, and more.
May 1, 2012

Featuring expert insights from GSK Biologicals, Baxter Pharmaceutical Solutions, GEA Pharma Systems, and more.

ADVERTISEMENT

ADVERTISEMENT

Click here